Status
Conditions
Treatments
About
This trial was designed as a prospective randomized, controlled, intervention, with two parallel groups, and a primary endpoint of recurrence during 12 months' follow-up after initial treatment, with the randomization, was performed by an online software a 1:1 allocation.
Full description
Eligibility Criteria
Exclusion
Interventions
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
59 participants in 2 patient groups
Loading...
Central trial contact
Mostafa shalaby, MD, MSc, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal